Spectrum	B:C3830325
-	I:C3830325
based	I:C3830325
and	I:C3830325
color	I:C3830325
-	I:C3830325
selective	I:C3830325
electrochemiluminescence	I:C3830325
immunoassay	I:C3830325
for	O
determining	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
in	O
near	O
-	I:C0205147
infrared	I:C0205147
region	I:C0205147
.	O

Spectrum	O
-	I:C3830325
based	I:C3830325
and	I:C3830325
color	I:C3830325
-	I:C3830325
selective	I:C3830325
electrochemiluminescence	I:C3830325
immunoassay	I:C3830325
for	O
determining	O
human	B:C0086418
prostate	O
specific	I:C0138741
antigen	I:C0138741
in	O
near	O
-	I:C0205147
infrared	I:C0205147
region	I:C0205147
.	O

Spectrum	O
-	I:C3830325
based	I:C3830325
and	I:C3830325
color	I:C3830325
-	I:C3830325
selective	I:C3830325
electrochemiluminescence	I:C3830325
immunoassay	I:C3830325
for	O
determining	O
human	O
prostate	B:C0138741
specific	I:C0138741
antigen	I:C0138741
in	O
near	O
-	I:C0205147
infrared	I:C0205147
region	I:C0205147
.	O

Spectrum	O
-	I:C3830325
based	I:C3830325
and	I:C3830325
color	I:C3830325
-	I:C3830325
selective	I:C3830325
electrochemiluminescence	I:C3830325
immunoassay	I:C3830325
for	O
determining	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
in	O
near	B:C0205147
-	I:C0205147
infrared	I:C0205147
region	I:C0205147
.	O

The	O
conventional	O
electrochemiluminescence	B:C3830326
(	O
electrochemiluminescence	O
)	O
analyses	O
were	O
performed	O
via	O
detecting	O
the	O
time	O
(	O
or	O
potential	O
)	O
dependent	O
electrochemiluminescence	O
intensity	O
with	O
the	O
proceeding	O
of	O
electrochemiluminescence	O
reaction	O
.	O

The	O
conventional	O
electrochemiluminescence	O
(	O
electrochemiluminescence	B:C3830326
)	O
analyses	O
were	O
performed	O
via	O
detecting	O
the	O
time	O
(	O
or	O
potential	O
)	O
dependent	O
electrochemiluminescence	O
intensity	O
with	O
the	O
proceeding	O
of	O
electrochemiluminescence	O
reaction	O
.	O

The	O
conventional	O
electrochemiluminescence	O
(	O
electrochemiluminescence	O
)	O
analyses	B:C0936012
were	O
performed	O
via	O
detecting	O
the	O
time	O
(	O
or	O
potential	O
)	O
dependent	O
electrochemiluminescence	O
intensity	O
with	O
the	O
proceeding	O
of	O
electrochemiluminescence	O
reaction	O
.	O

The	O
conventional	O
electrochemiluminescence	O
(	O
electrochemiluminescence	O
)	O
analyses	O
were	O
performed	O
via	O
detecting	O
the	O
time	O
(	O
or	O
potential	O
)	O
dependent	O
electrochemiluminescence	B:C3830326
intensity	O
with	O
the	O
proceeding	O
of	O
electrochemiluminescence	O
reaction	O
.	O

The	O
conventional	O
electrochemiluminescence	O
(	O
electrochemiluminescence	O
)	O
analyses	O
were	O
performed	O
via	O
detecting	O
the	O
time	O
(	O
or	O
potential	O
)	O
dependent	O
electrochemiluminescence	O
intensity	O
with	O
the	O
proceeding	O
of	O
electrochemiluminescence	B:C3830326
reaction	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	B:C3830326
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	B:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	B:C0205147
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	B:C0086418
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	B:C0138741
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	B:C0138741
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	B:C0054418
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	O
.	O

Herein	O
,	O
by	O
spectrally	O
recording	O
all	O
the	O
photons	O
generated	O
in	O
electrochemiluminescence	O
process	O
,	O
a	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
was	O
developed	O
in	O
near	O
-	I:C0205147
infrared	I:C0205147
(	I:C0205147
NIR	I:C0205147
)	I:C0205147
region	I:C0205147
with	O
human	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
(	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
)	O
as	O
target	O
and	O
dual	O
-	I:C0054418
stabilizers	I:C0054418
-	I:C0054418
capped	I:C0054418
CdTe	I:C0054418
nanocrystals	O
(	O
NCs	O
)	O
as	O
tags	B:C1139855
.	O

The	O
CdTe	B:C0054418
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	B:C3830326
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	B:C0003313
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	B:C3830326
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	B:C1979963
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	B:C0138741
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	B:C3830325
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	B:C0205147
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	B:C0544711
and	O
tissue	O
absorption	O
.	O

The	O
CdTe	O
NCs	O
displayed	O
efficient	O
electrochemiluminescence	O
around	O
780nm	O
with	O
the	O
full	O
width	O
at	O
half	O
-	O
maximum	O
around	O
70nm	O
in	O
the	O
immune	O
-	I:C0003313
complexes	I:C0003313
,	O
the	O
maximum	O
intensity	O
on	O
electrochemiluminescence	O
spectrum	O
profiles	O
increased	O
linearly	O
with	O
the	O
logarithmic	O
increased	O
concentration	O
of	O
prostate	O
specific	I:C0138741
antigen	I:C0138741
from	O
20.0fg	O
/	O
mL	O
to	O
100.0	O
pg	O
/	O
mL	O
,	O
indicating	O
a	O
sensitive	O
and	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
with	O
improved	O
anti-interference	O
performance	O
to	O
biological	O
autofluorescence	O
and	O
tissue	B:C0040300
absorption	O
.	O

The	O
spectral	B:C3830325
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
might	O
provide	O
an	O
important	O
technique	O
support	O
for	O
developing	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
assay	I:C3830325
of	O
different	O
wavebands	O
.	O

The	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	B:C0205147
region	I:C0205147
might	O
provide	O
an	O
important	O
technique	O
support	O
for	O
developing	O
color	O
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
assay	I:C3830325
of	O
different	O
wavebands	O
.	O

The	O
spectral	O
ECL	I:C3830325
immunoassay	I:C3830325
in	O
NIR	O
region	I:C0205147
might	O
provide	O
an	O
important	O
technique	O
support	O
for	O
developing	O
color	B:C3830325
-	I:C3830325
selective	I:C3830325
ECL	I:C3830325
assay	I:C3830325
of	O
different	O
wavebands	O
.	O

